The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study

The Five-year Pattern of Red Blood Cell Transfusion and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: A Korean Nationwide Longitudinal Cohort Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03776266

Acronym

TFPCI

Enrollment

48786

Registered

2018-12-14

Start date

2018-10-05

Completion date

2018-11-30

Last updated

2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erythrocyte Transfusion, Percutaneous Coronary Intervention, Revascularization

Keywords

Transfusion, PCI, Percutaneous Coronary Intervention

Brief summary

A nationwide retrospective cohort study. To investigate the long-term patterns of transfusion and clinical outcomes of patients undergoing PCI.

Detailed description

A nationwide retrospective cohort study. Transfusion after PCI may increase a risk, but the long term effects after red blood cell transfusion is known. Longitudinal data is collected from administrative claims in the National Healthcare Insurance Service of Korea. All Korean patient date undergoing PCI inserting stent from January 1, 2011 to December 31, 2011 is extracted. Clinical outcomes until December 31, 2016 is investigated. Primary outcome is the incidence density of red blood cell transfusion. Secondary outcomes are the association of transfusion with major adverse clinical event (MACE) consisting all-cause death, revascularization, critically ill cardiovascular status, or stroke. Incidence density and time-dependent Cox proportional hazard regression is statistically analyzed.

Interventions

PROCEDURENo intervention is required due to retrospective observational study

Red blood cell transfusion on or after percutaneous coronary intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All Korean patients undergoing PCI using stent from January 1, 2011 to December 31, 2011

Exclusion criteria

* Patients without any stent insertion

Design outcomes

Primary

Measure	Time frame	Description
Incidence density of transfusion	5 years	5-year incidence density of red blood cell transfusion

Secondary

Measure	Time frame	Description
Incidence density of MACE	5 years	5-year incidence densities of a major adverse clinical event (MACE) consisting of all-cause death, revascularization, critically ill cardiovascular status, and stroke

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026